Serum concentrations of gentamicin in patients with myelomeningocele

M C Nahata1, D C McComb, P R Schad

  • 1College of Pharmacy, Ohio State University, Columbus 43210.

Insights

Monitoring gentamicin levels is crucial for adjusting doses in myelomeningocele patients. This individualized approach helps maintain safe peak and trough serum concentrations, improving therapeutic outcomes.

Area of Science:

  • Pharmacokinetics
  • Pediatric Nephrology
  • Neurology

Background:

  • Gentamicin is an antibiotic commonly used for bacterial infections.
  • Myelomeningocele, a severe birth defect, can affect drug metabolism and excretion.
  • Accurate dosing is essential to maximize efficacy and minimize toxicity.

Purpose of the Study:

  • To evaluate the necessity of monitoring gentamicin serum concentrations in patients with myelomeningocele.
  • To determine if dose adjustments are required to maintain therapeutic gentamicin levels.
  • To assess the potential of individualized dosing for improved patient outcomes.

Main Methods:

  • Serum concentrations of gentamicin were measured in 18 pediatric and adult patients.
  • Peak and trough levels were monitored to assess drug exposure.
  • Dose adjustments were made based on individual patient serum concentrations.

Main Results:

  • Dose adjustments were necessary for 6 out of 18 patients (33.3%).
  • Adjustments were made to maintain peak concentrations below 8 µg/mL and trough concentrations below 2 µg/mL.
  • Individualized monitoring facilitated achievement of target gentamicin levels.

Conclusions:

  • Serum concentration monitoring of gentamicin is valuable for individualizing doses in myelomeningocele patients.
  • Further research is needed to establish specific dosing guidelines for different age groups and disease severities.
  • Optimized gentamicin therapy can be achieved through personalized dose adjustments.